Eriko Aimono

654 total citations
40 papers, 374 citations indexed

About

Eriko Aimono is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eriko Aimono has authored 40 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eriko Aimono's work include Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Eriko Aimono is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Eriko Aimono collaborates with scholars based in Japan. Eriko Aimono's co-authors include Hiroshi Nishihara, Kohei Nakamura, Shigeki Tanishima, Mototsugu Oya, Shuji Mikami, Hideyuki Hayashi, Takeo Kosaka, Hiroshi Hongo, Tatsuyuki Chiyoda and Kazuhiro Kakimi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Eriko Aimono

39 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eriko Aimono Japan	12	192	128	118	84	82	40	374
Prasanth Reddy United States	8	205 1.1×	158 1.2×	117 1.0×	101 1.2×	33 0.4×	28	386
Christopher DiSimone United States	6	271 1.4×	148 1.2×	85 0.7×	114 1.4×	60 0.7×	10	490
Yasmine Baca United States	10	174 0.9×	83 0.6×	75 0.6×	94 1.1×	29 0.4×	56	292
Alessandra Anna Prete Italy	9	388 2.0×	158 1.2×	144 1.2×	66 0.8×	37 0.5×	27	497
Pritesh Trivedi United Kingdom	11	189 1.0×	83 0.6×	88 0.7×	139 1.7×	44 0.5×	20	402
B Marmey France	6	149 0.8×	138 1.1×	66 0.6×	103 1.2×	51 0.6×	6	340
Todd Maney United States	5	389 2.0×	130 1.0×	100 0.8×	73 0.9×	67 0.8×	9	484
Masashi Mikubo Japan	12	213 1.1×	256 2.0×	96 0.8×	119 1.4×	32 0.4×	40	458
Vanesa Rojas‐Rudilla United States	6	142 0.7×	113 0.9×	124 1.1×	97 1.2×	157 1.9×	8	362
P. Iyengar Canada	12	152 0.8×	109 0.9×	70 0.6×	150 1.8×	104 1.3×	24	517

Countries citing papers authored by Eriko Aimono

Since Specialization

Citations

This map shows the geographic impact of Eriko Aimono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Aimono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Aimono more than expected).

Fields of papers citing papers by Eriko Aimono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Aimono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Aimono. The network helps show where Eriko Aimono may publish in the future.

Co-authorship network of co-authors of Eriko Aimono

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Aimono. A scholar is included among the top collaborators of Eriko Aimono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Aimono. Eriko Aimono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakamura, Kohei, Tatsuyuki Chiyoda, Reika Takamatsu, et al.. (2025). Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification. PubMed. 3(1). 37–37. 1 indexed citations

Kodama, Makoto, Eriko Aimono, Kohei Nakamura, et al.. (2025). CXCL9 and CXCL13 shape endometrial cancer immune‐activated microenvironment via tertiary lymphoid structure formation. Cancer Science. 116(5). 1193–1202. 2 indexed citations

Oe, Yuki, Takashi Omori, Eriko Aimono, et al.. (2025). Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide. Frontiers in Endocrinology. 16. 1501984–1501984. 2 indexed citations

Nakamura, Kohei, Ryutaro Kawano, Eriko Aimono, et al.. (2024). Characterizing multi‐PIK3CA mutations across cancer types: Toward precision oncology. Cancer Medicine. 13(14). e70052–e70052. 4 indexed citations

Nakano, Yutaka, Kohei Nakamura, Reika Takamatsu, et al.. (2024). Next‑generation sequencing to identify genetic mutations in pancreatic cancer using intraoperative peritoneal washing fluid. Oncology Letters. 27(4). 139–139. 1 indexed citations

Yanagita, Emmy, Hiroshi Yamada, T. Kobayashi, et al.. (2023). The DNA integrity number and concentration are useful parameters for successful comprehensive genomic profiling test for cancer using formalin‐fixed paraffin embedded tissue. Pathology International. 73(5). 198–206. 2 indexed citations

Akahane, Toshiaki, Nobuyuki Bandoh, Eriko Aimono, et al.. (2023). Cancer gene analysis of liquid‐based cytology specimens using next‐generation sequencing: A technical report of bimodal DNA‐ and RNA‐based panel application. Diagnostic Cytopathology. 51(8). 493–500. 5 indexed citations

Hayashi, Hideyuki, Kei Kunimasa, Shigeki Tanishima, et al.. (2023). Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling. Cancer Science. 115(2). 682–686. 5 indexed citations

Matsuda, Satoru, Hirofumi Kawakubo, Kohei Nakamura, et al.. (2023). Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 30(6). 3747–3756. 16 indexed citations

10.

Takamatsu, Reika, Kohei Nakamura, Okihide Suzuki, et al.. (2023). Clinical predominance of whole‐exome sequencing to evaluate microsatellite instability status. Cancer Science. 114(7). 2848–2859. 3 indexed citations

11.

Matsuda, Satoru, Hirofumi Kawakubo, Kohei Nakamura, et al.. (2023). ASO Visual Abstract: Tumor Burden Monitoring with Circulating Tumor DNA During Treatment in Patients with Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 30(6). 3759–3759. 4 indexed citations

12.

Matsuda, Satoru, Hirofumi Kawakubo, Shigeo Yamaguchi, et al.. (2022). Elevation of the Prognostic Factor Plasma Fibrinogen Reflects the Immunosuppressive Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 29(11). 6894–6904. 6 indexed citations

13.

Shibuya, Makoto, Kentaro Ohara, Yasutaka Kato, et al.. (2022). The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas. Brain Tumor Pathology. 39(2). 79–87.

14.

Nakamura, Kohei, Eriko Aimono, Junna Oba, et al.. (2021). Estimating copy number using next-generation sequencing to determine ERBB2 amplification status. Medical Oncology. 38(4). 36–36. 19 indexed citations

15.

Shimozaki, Keitaro, Hideyuki Hayashi, Shigeki Tanishima, et al.. (2021). Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors. Scientific Reports. 11(1). 20003–20003. 31 indexed citations

16.

Chiyoda, Tatsuyuki, Miho Kawaida, Kohei Nakamura, et al.. (2021). ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer. Gynecologic Oncology. 162(3). 679–685. 28 indexed citations

17.

Kosaka, Takeo, Hiroshi Hongo, Eriko Aimono, et al.. (2021). Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification. SHILAP Revista de lepidopterología. 4(4). 216–219. 6 indexed citations

18.

Hongo, Hiroshi, Takeo Kosaka, Eriko Aimono, Hiroshi Nishihara, & Mototsugu Oya. (2020). Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report. Diagnostic Pathology. 15(1). 5–5. 6 indexed citations

19.

Nakamura, Kohei, Eriko Aimono, Shigeki Tanishima, et al.. (2020). Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report. Diagnostic Pathology. 15(1). 64–64. 11 indexed citations

20.

Watanabe, Keitaro, Takeo Kosaka, Eriko Aimono, et al.. (2019). Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy. Clinical Genitourinary Cancer. 17(5). e897–e902. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact